ARCHIVES

It is The First FDA Withdrawl Of An Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

M.D. Anderson, Madrid In Joint Program

September 2, 1988

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014